Cargando…

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme

The COVID-19 pandemic caused by SARS-CoV-2 infection has placed health systems under excessive pressure and especially elderly people with cancer. Glioblastoma multiforme (GBM) is a malignant brain tumor with an increasing incidence in elderly individuals, and thereby GBM patients are a vulnerable p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Anjing, Zhao, Wenguo, Li, Xiaolong, Sun, Guangyu, Ma, Zhaoyin, Peng, Lingyu, Shi, Zhongyang, Li, Xingang, Yan, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020264/ https://www.ncbi.nlm.nih.gov/pubmed/35464443 http://dx.doi.org/10.3389/fimmu.2022.840785

Ejemplares similares

Current Immunotherapies for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2021)

Advances in immunotherapy for glioblastoma multiforme
por: Mahmoud, Ahmad Bakur, et al.
Publicado: (2022)

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment
por: Pearson, Joshua R. D., et al.
Publicado: (2020)

Comprehensive analysis of a long non-coding RNA-mediated competitive endogenous RNA network in glioblastoma multiforme
por: Long, Shengrong, et al.
Publicado: (2019)

Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme
por: Jan, Chia-Ing, et al.
Publicado: (2018)

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
por: Cai, Xiaomin, et al.
Publicado: (2022)

Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics
por: Li, Rui, et al.
Publicado: (2015)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Genomic and Epigenomic Features of Glioblastoma Multiforme and its Biomarkers
por: Jadoon, Sarmad Sheraz, et al.
Publicado: (2022)

Pan-cancer analysis of ASB3 and the potential clinical implications for immune microenvironment of glioblastoma multiforme
por: Mu, Long, et al.
Publicado: (2022)

Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
por: Heiland, Dieter Henrik, et al.
Publicado: (2017)

Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme
por: Zhang, Yan, et al.
Publicado: (2018)

Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network
por: Zheng, Jianglin, et al.
Publicado: (2022)

Corrigendum: Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme
por: Zhang, Yan, et al.
Publicado: (2020)

Activity and Cellular Localization of an Oncogenic Glioblastoma Multiforme-associated EGF Receptor Mutant Possessing a Duplicated Kinase Domain
por: Ozer, Byram H., et al.
Publicado: (2009)

Comprehensive Analysis of the Brain-Expressed X-Link Protein Family in Glioblastoma Multiforme
por: Aisa, Adilai, et al.
Publicado: (2022)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Plasma PD-L1 as a biomarker in the clinical management of glioblastoma multiforme—a retrospective cohort study
por: Masood, Aetsam Bin, et al.
Publicado: (2023)

The use of radiosensitizing agents in the therapy of glioblastoma multiforme—a comprehensive review
por: Pepper, Niklas Benedikt, et al.
Publicado: (2022)

Prolactin and its receptor as therapeutic targets in glioblastoma multiforme
por: Asad, Antonela Sofía, et al.
Publicado: (2019)

Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
por: Tilak, Manali, et al.
Publicado: (2021)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Survival Analysis of Glioblastoma Multiforme
por: Witthayanuwat, Supapan, et al.
Publicado: (2018)

Advances in Immunotherapy for Glioblastoma Multiforme
por: Huang, Boyuan, et al.
Publicado: (2017)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Prion Protein in Glioblastoma Multiforme
por: Ryskalin, Larisa, et al.
Publicado: (2019)

Glioblastoma Multiforme Masquerading as Stroke
por: Remley, William, et al.
Publicado: (2021)

circRPPH1_025 Overexpression Promotes Migration and Invasion of Glioblastoma Multiforme
por: Xue, Lixiong, et al.
Publicado: (2022)

Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme
por: Li, Hao, et al.
Publicado: (2021)

Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New Perspectives
por: Corsi, Lorenzo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2kp9o7vjrvgaucf53fgq6t1d51